## Abstract ## BACKGROUND Preclinical data suggest that the combination of intravenous (i.v.) paclitaxel, carboplatin, oral etoposide, and oral estramustine (TEEC) has significant activity in patients with advanced, hormoneβrefractory prostate carcinoma. The authors conducted this clinical trial t
β¦ LIBER β¦
Role of c-myc protein in hormone refractory prostate carcinoma: cellular response to paclitaxel
β Scribed by Giuliana Cassinelli; Rosanna Supino; Valentina Zuco; Cinzia Lanzi; A.Ivana Scovassi; Sean C Semple; Franco Zunino
- Book ID
- 113487282
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 356 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0006-2952
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Phase II trial of paclitaxel, estramusti
β
David C. Smith; Christopher H. Chay; Rodney L. Dunn; Jude Fardig; Peg Esper; Kar
π
Article
π
2003
π
John Wiley and Sons
π
English
β 127 KB
π 1 views
A Phase I/II study of weekly paclitaxel
β
Anna C. Ferrari; Abraham Chachoua; Harvinder Singh; Mark Rosenthal; Samir Taneja
π
Article
π
2001
π
John Wiley and Sons
π
English
β 82 KB
π 2 views
A retrospective evaluation of second-lin
β
Jonathan E. Rosenberg; Matthew D. Galsky; Nicholas C. Rohs; Vivian K. Weinberg;
π
Article
π
2006
π
John Wiley and Sons
π
English
β 101 KB
Role of diacylglycerol (DAG) in hormonal
β
Olav F. Dajani; Dagny Sandnes; Γyvind Melien; Firous Rezvani; Laila S. Nilssen;
π
Article
π
1999
π
John Wiley and Sons
π
English
β 261 KB
π 3 views
The role of diacylglycerol (DAG) in hormonal induction of S phase was investigated in primary cultures of rat hepatocytes. In this model, several agonists that bind to G protein-coupled receptors act as comitogens when added to the cells soon after plating (i.e., in Go/early Gl phase), while the cel